This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Margolis, P. S.
Right arrow Articles by Trias, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Margolis, P. S.
Right arrow Articles by Trias, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2000, p. 1825-1831, Vol. 44, No. 7
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Peptide Deformylase in Staphylococcus aureus: Resistance to Inhibition Is Mediated by Mutations in the Formyltransferase Gene

Peter S. Margolis, Corinne J. Hackbarth, Dennis C. Young, Wen Wang, Dawn Chen, Zhengyu Yuan, Richard White, and Joaquim Trias*

Versicor, Inc., Fremont, California 94555

Received 15 November 1999/Returned for modification 17 March 2000/Accepted 5 April 2000

Peptide deformylase, a bacterial enzyme, represents a novel target for antibiotic discovery. Two deformylase homologs, defA and defB, were identified in Staphylococcus aureus. The defA homolog, located upstream of the transformylase gene, was identified by genomic analysis and was cloned from chromosomal DNA by PCR. A distinct homolog, defB, was cloned from an S. aureus genomic library by complementation of the arabinose-dependent phenotype of a PBAD-def Escherichia coli strain grown under arabinose-limiting conditions. Overexpression in E. coli of defB, but not defA, correlated to increased deformylase activity and decreased susceptibility to actinonin, a deformylase-specific inhibitor. The defB gene could not be disrupted in wild-type S. aureus, suggesting that this gene, which encodes a functional deformylase, is essential. In contrast, the defA gene could be inactivated; the function of this gene is unknown. Actinonin-resistant mutants grew slowly in vitro and did not show cross-resistance to other classes of antibiotics. When compared to the parent, an actinonin-resistant strain produced an attenuated infection in a murine abscess model, indicating that this strain also has a growth disadvantage in vivo. Sequence analysis of the actinonin-resistant mutants revealed that each harbors a loss-of-function mutation in the fmt gene. Susceptibility to actinonin was restored when the wild-type fmt gene was introduced into these mutant strains. An S. aureus Delta fmt strain was also resistant to actinonin, suggesting that a functional deformylase activity is not required in a strain that lacks formyltransferase activity. Accordingly, the defB gene could be disrupted in an fmt mutant.


* Corresponding author. Mailing address: Versicor, Inc., 34790 Ardentech Court, Fremont, CA 94555. Phone: (510) 739-3025. Fax: (510) 739-3003. E-mail: jtrias{at}versicor.com.


Antimicrobial Agents and Chemotherapy, July 2000, p. 1825-1831, Vol. 44, No. 7
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Duroc, Y., Giglione, C., Meinnel, T. (2009). Mutations in Three Distinct Loci Cause Resistance to Peptide Deformylase Inhibitors in Bacillus subtilis. Antimicrob. Agents Chemother. 53: 1673-1678 [Abstract] [Full Text]  
  • Saxena, R., Kanudia, P., Datt, M., Dar, H. H., Karthikeyan, S., Singh, B., Chakraborti, P. K. (2008). Three Consecutive Arginines Are Important for the Mycobacterial Peptide Deformylase Enzyme Activity. J. Biol. Chem. 283: 23754-23764 [Abstract] [Full Text]  
  • Dean, C. R., Narayan, S., Richards, J., Daigle, D. M., Esterow, S., Leeds, J. A., Kamp, H., Puyang, X., Wiedmann, B., Mueller, D., Voshol, H., van Oostrum, J., Wall, D., Koehn, J., Dzink-Fox, J., Ryder, N. S. (2007). Reduced Susceptibility of Haemophilus influenzae to the Peptide Deformylase Inhibitor LBM415 Can Result from Target Protein Overexpression Due to Amplified Chromosomal def Gene Copy Number. Antimicrob. Agents Chemother. 51: 1004-1010 [Abstract] [Full Text]  
  • Teo, J. W. P., Thayalan, P., Beer, D., Yap, A. S. L., Nanjundappa, M., Ngew, X., Duraiswamy, J., Liung, S., Dartois, V., Schreiber, M., Hasan, S., Cynamon, M., Ryder, N. S., Yang, X., Weidmann, B., Bracken, K., Dick, T., Mukherjee, K. (2006). Peptide Deformylase Inhibitors as Potent Antimycobacterial Agents. Antimicrob. Agents Chemother. 50: 3665-3673 [Abstract] [Full Text]  
  • Huang, J., Van Aller, G. S., Taylor, A. N., Kerrigan, J. J., Liu, W.-S., Trulli, J. M., Lai, Z., Holmes, D., Aubart, K. M., Brown, J. R., Zalacain, M. (2006). Phylogenomic and Biochemical Characterization of Three Legionella pneumophila Polypeptide Deformylases.. J. Bacteriol. 188: 5249-5257 [Abstract] [Full Text]  
  • Nilsson, A. I., Zorzet, A., Kanth, A., Dahlstrom, S., Berg, O. G., Andersson, D. I. (2006). Reducing the fitness cost of antibiotic resistance by amplification of initiator tRNA genes. Proc. Natl. Acad. Sci. USA 103: 6976-6981 [Abstract] [Full Text]  
  • Wang, W., White, R., Yuan, Z. (2006). Proteomic Study of Peptide Deformylase Inhibition in Streptococcus pneumoniae and Staphylococcus aureus.. Antimicrob. Agents Chemother. 50: 1656-1663 [Abstract] [Full Text]  
  • Watters, A. A., Jones, R. N., Leeds, J. A., Denys, G., Sader, H. S., Fritsche, T. R. (2006). Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004). J Antimicrob Chemother 57: 914-923 [Abstract] [Full Text]  
  • D'Orazio, S. E.F., Shaw, C. A., Starnbach, M. N. (2006). H2-M3-restricted CD8+ T cells are not required for MHC class Ib-restricted immunity against Listeria monocytogenes. JEM 203: 383-391 [Abstract] [Full Text]  
  • Saxena, R., Chakraborti, P. K. (2005). Identification of Regions Involved in Enzymatic Stability of Peptide Deformylase of Mycobacterium tuberculosis. J. Bacteriol. 187: 8216-8220 [Abstract] [Full Text]  
  • Fritsche, T. R., Sader, H. S., Cleeland, R., Jones, R. N. (2005). Comparative Antimicrobial Characterization of LBM415 (NVP PDF-713), a New Peptide Deformylase Inhibitor of Clinical Importance. Antimicrob. Agents Chemother. 49: 1468-1476 [Abstract] [Full Text]  
  • Vido, K., Diemer, H., Van Dorsselaer, A., Leize, E., Juillard, V., Gruss, A., Gaudu, P. (2005). Roles of Thioredoxin Reductase during the Aerobic Life of Lactococcus lactis. J. Bacteriol. 187: 601-610 [Abstract] [Full Text]  
  • Steiner-Mosonyi, M., Creuzenet, C., Keates, R. A. B., Strub, B. R., Mangroo, D. (2004). The Pseudomonas aeruginosa Initiation Factor IF-2 Is Responsible for Formylation-independent Protein Initiation in P. aeruginosa. J. Biol. Chem. 279: 52262-52269 [Abstract] [Full Text]  
  • Haas, P.-J., de Haas, C. J. C., Kleibeuker, W., Poppelier, M. J. J. G., van Kessel, K. P. M., Kruijtzer, J. A. W., Liskamp, R. M. J., van Strijp, J. A. G. (2004). N-Terminal Residues of the Chemotaxis Inhibitory Protein of Staphylococcus aureus Are Essential for Blocking Formylated Peptide Receptor but Not C5a Receptor. J. Immunol. 173: 5704-5711 [Abstract] [Full Text]  
  • Gil, R., Silva, F. J., Pereto, J., Moya, A. (2004). Determination of the Core of a Minimal Bacterial Gene Set. Microbiol. Mol. Biol. Rev. 68: 518-537 [Abstract] [Full Text]  
  • Jones, R. N., Moet, G. J., Sader, H. S., Fritsche, T. R. (2004). Potential utility of a peptide deformylase inhibitor (NVP PDF-713) against oxazolidinone-resistant or streptogramin-resistant Gram-positive organism isolates. J Antimicrob Chemother 53: 804-807 [Abstract] [Full Text]  
  • Hackbarth, C. J., Chen, D. Z., Lewis, J. G., Clark, K., Mangold, J. B., Cramer, J. A., Margolis, P. S., Wang, W., Koehn, J., Wu, C., Lopez, S., Withers, G. III, Gu, H., Dunn, E., Kulathila, R., Pan, S.-H., Porter, W. L., Jacobs, J., Trias, J., Patel, D. V., Weidmann, B., White, R. J., Yuan, Z. (2002). N-Alkyl Urea Hydroxamic Acids as a New Class of Peptide Deformylase Inhibitors with Antibacterial Activity. Antimicrob. Agents Chemother. 46: 2752-2764 [Abstract] [Full Text]  
  • Margolis, P., Hackbarth, C., Lopez, S., Maniar, M., Wang, W., Yuan, Z., White, R., Trias, J. (2001). Resistance of Streptococcus pneumoniae to Deformylase Inhibitors Is Due to Mutations in defB. Antimicrob. Agents Chemother. 45: 2432-2435 [Abstract] [Full Text]  
  • Dirk, L. M.A., Williams, M. A., Houtz, R. L. (2001). Eukaryotic Peptide Deformylases. Nuclear-Encoded and Chloroplast-Targeted Enzymes in Arabidopsis. Plant Physiol. 127: 97-107 [Abstract] [Full Text]  
  • Haas, M., Beyer, D., Gahlmann, R., Freiberg, C. (2001). YkrB is the main peptide deformylase in Bacillus subtilis, a eubacterium containing two functional peptide deformylases. Microbiology 147: 1783-1791 [Abstract] [Full Text]  
  • O'Neill, A. J., Chopra, I., Martínez, J. L., Baquero, F. (2001). Use of Mutator Strains for Characterization of Novel Antimicrobial Agents. Antimicrob. Agents Chemother. 45: 1599-1600 [Full Text]  
  • Clements, J. M., Beckett, R. P., Brown, A., Catlin, G., Lobell, M., Palan, S., Thomas, W., Whittaker, M., Wood, S., Salama, S., Baker, P. J., Rodgers, H. F., Barynin, V., Rice, D. W., Hunter, M. G. (2001). Antibiotic Activity and Characterization of BB-3497, a Novel Peptide Deformylase Inhibitor. Antimicrob. Agents Chemother. 45: 563-570 [Abstract] [Full Text]